Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Dutt

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Cancer Medicine|September 29, 2018
Analysis of solid tumor mutation profiles in liquid biopsySai A Balaji, Ashwini Shanmugam, Anuradha Chougule, et al.
International Journal of Cancer|October 11, 2018
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancerPrajish Iyer, Shailesh V Shrikhande, Malika Ranjan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2008
Drug-sensitive FGFR2 mutations in endometrial carcinomaAmit Dutt, Helga B Salvesen, Tzu-Hsiu Chen, et al.
Cancer Biology & Therapy|September 17, 2009
Amplification of chromosomal segment 4q12 in non-small cell lung cancerAlex H Ramos, Amit Dutt, Craig Mermel, et al.
Cancer Cell|November 20, 2018
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain MutationsKanika Bajaj Pahuja, Thong T Nguyen, Bijay S Jaiswal, et al.
The Lancet Regional Health. Southeast Asia|August 19, 2024
Uniqueness of lung cancer in Southeast AsiaVanita Noronha, Atul Budukh, Pankaj Chaturvedi, et al.
Nature Genetics|October 6, 2009
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasAdam J Bass, Hideo Watanabe, Craig H Mermel, et al.
Nature Genetics|February 13, 2007
High-throughput oncogene mutation profiling in human cancerRoman K Thomas, Alissa C Baker, Ralph M Debiasi, et al.
Cancer Discovery|February 14, 2012
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancerPeter S Hammerman, Martin L Sos, Alex H Ramos, et al.
Nature|October 25, 2008
Somatic mutations affect key pathways in lung adenocarcinomaLi Ding, Gad Getz, David A Wheeler, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cancer Medicine|September 29, 2018
Analysis of solid tumor mutation profiles in liquid biopsySai A Balaji, Ashwini Shanmugam, Anuradha Chougule, et al.
International Journal of Cancer|October 11, 2018
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancerPrajish Iyer, Shailesh V Shrikhande, Malika Ranjan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2008
Drug-sensitive FGFR2 mutations in endometrial carcinomaAmit Dutt, Helga B Salvesen, Tzu-Hsiu Chen, et al.
Cancer Biology & Therapy|September 17, 2009
Amplification of chromosomal segment 4q12 in non-small cell lung cancerAlex H Ramos, Amit Dutt, Craig Mermel, et al.
Cancer Cell|November 20, 2018
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain MutationsKanika Bajaj Pahuja, Thong T Nguyen, Bijay S Jaiswal, et al.
The Lancet Regional Health. Southeast Asia|August 19, 2024
Uniqueness of lung cancer in Southeast AsiaVanita Noronha, Atul Budukh, Pankaj Chaturvedi, et al.
Nature Genetics|October 6, 2009
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasAdam J Bass, Hideo Watanabe, Craig H Mermel, et al.
Nature Genetics|February 13, 2007
High-throughput oncogene mutation profiling in human cancerRoman K Thomas, Alissa C Baker, Ralph M Debiasi, et al.
Cancer Discovery|February 14, 2012
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancerPeter S Hammerman, Martin L Sos, Alex H Ramos, et al.
Nature|October 25, 2008
Somatic mutations affect key pathways in lung adenocarcinomaLi Ding, Gad Getz, David A Wheeler, et al.
Pageof 9